Viewing nowEsomeprazole Magnesium Hydrate 40mg
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 201506636 · Approved 2015.09.18 · Insurance code 653805110
Treatment of reflux disease, gastrointestinal disorders (e.g., ulcers, H. pylori eradication, and drug-induced symptoms), and Zollinger-Ellison syndrome
This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps alleviate symptoms in patients with gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the prevention of recurrence in patients with Helicobacter pylori infection and duodenal or peptic ulcers. It is effective for the treatment and prevention of upper gastrointestinal symptoms or gastric ulcers and duodenal ulcers related to non-steroidal anti-inflammatory drug use. It is also applied for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after prevention of rebleeding of gastric or duodenal ulcers following intravenous administration. Overall, it is used for the treatment and prevention of various digestive diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms continue should take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent episodes can be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. As-needed use to control ongoing symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continued nonsteroidal anti-inflammatory drug use - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses per day. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous injection Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous injection. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. The dose of this medicine should not exceed 20 mg in patients with severe hepatic impairment. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms continue should take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes can be controlled by administering 20 mg once daily. 3. Children under 12 years of age There is no experience with administering this medicine to children under 12 years of age.
This medication should not be used in patients who are allergic to specific components or have had hypersensitivity reactions. Caution is also warranted in patients allergic to penicillin antibiotics or macrolide antibiotics. Patients taking certain cardiac medications or antivirals, as well as women with a history of myocardial infarction or those who are nursing, should avoid taking this medication. This medication can cause various side effects, so if symptoms like headache, abdominal pain, diarrhea, skin rash, muscle pain, or blood abnormalities occur, medical consultation should be sought immediately. Regular examinations are needed for long-term use, particularly to periodically check magnesium levels and liver function. This medication may increase bacterial growth in the stomach by reducing gastric acid, so if symptoms of diarrhea or infection persist, medical attention should be sought. Additionally, there may be an increased risk of fractures, so caution is needed in patients with osteoporosis or a high risk of fractures. This medication can interact with other drugs, so it is essential to inform healthcare professionals of any ongoing medications. Care should be particularly taken when used with medications affecting blood coagulation, antibiotics, antivirals, and immunosuppressants. The safety of this medication has not been fully established during pregnancy, so pregnant patients should discuss use with their physician. It is recommended that nursing women do not take this medication. In cases of overdose, as there is no specific antidote, immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children and transferring it to another container should be avoided.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, eosinophilia, drug reaction with systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbated depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, aggravated migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, erythematous rash, papular rash, otitis media, olfactory disturbance, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, mucosal pigmentation, exacerbation of malignant tumor symptoms, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. To maintain effectiveness, it is important to store it at room temperature between 1 degree and 30 degrees.
Pink round film-coated tablet
Box - 28 tablets/box [14 tablets/PTP x 2], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.